• LAST PRICE
    13.6000
  • TODAY'S CHANGE (%)
    Trending Up0.3400 (2.5641%)
  • Bid / Lots
    13.1000/ 1
  • Ask / Lots
    21.0000/ 9
  • Open / Previous Close
    12.9700 / 13.2600
  • Day Range
    Low 12.0700
    High 14.0400
  • 52 Week Range
    Low 5.9000
    High 21.0000
  • Volume
    81,411
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 13.26
TimeVolumeRLYB
09:32 ET154512.68
09:36 ET60012.7
09:39 ET50012.65
09:41 ET43012.61
09:48 ET50012.5
09:50 ET108012.4
09:52 ET10012.41
10:01 ET40012.3
10:03 ET10012.17
10:10 ET70012.07
10:15 ET40012.35
10:17 ET40012.3004
10:21 ET80012.49
10:24 ET30012.38
10:37 ET140012.35
10:39 ET20012.36
10:42 ET10012.46
10:46 ET124012.33
10:48 ET10012.645
10:50 ET240312.66
10:51 ET60012.98
10:53 ET10012.87
10:57 ET10012.85
11:00 ET30012.8
11:06 ET20012.77
11:08 ET10012.82
11:09 ET10012.83
11:11 ET10012.8
11:13 ET10012.59
11:15 ET30012.64
11:18 ET50012.74
11:24 ET140012.84
11:40 ET10012.7
11:42 ET20012.699
11:44 ET123912.905
11:47 ET10012.85
11:49 ET70012.935
11:51 ET40013
12:02 ET30013.15
12:03 ET100013.18
12:05 ET10013.1
12:07 ET10013.06
12:14 ET10012.98
12:18 ET10012.91
12:21 ET20012.73
12:23 ET10012.91
12:30 ET10012.955
12:32 ET10012.955
12:34 ET10012.95
12:38 ET50013.13
12:41 ET10013.29
12:43 ET10013.29
12:45 ET20013.03
12:48 ET10013.27
12:52 ET10013.29
12:54 ET20013.025
12:59 ET10013.22
01:03 ET30013.275
01:06 ET10013.025
01:12 ET30013.3
01:14 ET20013.1
01:19 ET10013.29
01:21 ET40013.39
01:28 ET26313.49
01:30 ET30013.5
01:37 ET142913.59
01:42 ET10013.39
01:46 ET10013.15
01:53 ET30013.46
01:57 ET113213.5178
02:00 ET20013.64
02:02 ET50013.65
02:04 ET10013.405
02:06 ET30013.6
02:08 ET128613.785
02:09 ET10013.73
02:11 ET10013.71
02:13 ET69013.77
02:15 ET10013.61
02:18 ET20013.53
02:20 ET10013.59
02:27 ET59813.755
02:31 ET20013.98
02:33 ET30014.04
02:38 ET49613.7
02:40 ET137713.66
02:51 ET10013.59
02:58 ET99613.745
03:00 ET10013.74
03:03 ET10013.27
03:12 ET40013.55
03:14 ET10013.56
03:16 ET229913.425
03:18 ET40013.45
03:23 ET50013.44
03:25 ET10013.685
03:27 ET20013.41
03:34 ET40013.5
03:38 ET10013.41
03:39 ET20013.5
03:41 ET20013.41
03:43 ET10013.67
03:45 ET20013.52
03:48 ET30013.525
03:50 ET20013.555
03:52 ET40013.54
03:54 ET80013.44
03:56 ET120013.72
03:57 ET170013.78
03:59 ET90013.6
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRLYB
Rallybio Corp
557.9M
-7.4x
---
United StatesIPSC
Century Therapeutics Inc
560.6M
-4.4x
---
United StatesKZR
Kezar Life Sciences Inc
548.3M
-7.7x
---
United StatesIMVT
Immunovant Inc
568.9M
-3.3x
---
United StatesHLVX
Hillevax Inc
571.9M
0.0x
---
United StatesEWTX
Edgewise Therapeutics Inc
576.6M
-8.0x
---
As of 2022-09-25

Company Information

Rallybio Corporation is a clinical-stage biotechnology company. The Company is engaged in discovering, developing, manufacturing and delivering therapies that improve the lives of patients suffering from severe and rare diseases. It offers a program for the prevention of fetal and neonatal alloimmune thrombocytopenia, a rare hematological disease that impacts fetuses and newborns. It provides RLYB211, a polyclonal anti-HPA-1a antibody. Its RLYB211 is in Phase I/II clinical trial. The Company’s lead product candidate, RLYB212, is a monoclonal anti-HPA-1a antibody. It is also focused on developing therapies that address diseases of complement dysregulation, including paroxysmal nocturnal hemoglobinuria (PNH), generalized myasthenia gravis (gMG), and ophthalmic disorders. Its RLYB116 is a long-acting, subcutaneously administered inhibitor of complement factor 5 (C5) in development for the treatment of patients with PNH and gMG. It also includes RLYB114, which is a pegylated C5 inhibitor.

Contact Information

Headquarters
234 CHURCH STREET, SUITE 1020NEW HAVEN, CT, United States 06510
Phone
203-859-3820
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Martin Mackay
President, Co-Founder, Chief Operating Officer, Chief Scientific Officer
Stephen Uden
Co-Founder, Chief Financial Officer, Treasurer
Jeffrey Fryer
Chief Medical Officer
Steven Ryder
Director
Wendy Chung

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$557.9M
Revenue (TTM)
$0.00
Shares Outstanding
41.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.84
Book Value
$5.47
P/E Ratio
-7.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.